Showing 1 to 3 of 3 results


Mother's Death Highlights Urgent Need for Earlier Breast Cancer Detection
32-year-old Lisa Foster from Hampshire died from stage four triple-negative ductal sarcoma after mistaking an early symptom for a gym injury, prompting a warning for women to seek medical attention for any breast changes and highlighting the need for earlier breast cancer screenings.
Mother's Death Highlights Urgent Need for Earlier Breast Cancer Detection
32-year-old Lisa Foster from Hampshire died from stage four triple-negative ductal sarcoma after mistaking an early symptom for a gym injury, prompting a warning for women to seek medical attention for any breast changes and highlighting the need for earlier breast cancer screenings.
Progress
40% Bias Score


Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks
Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.
Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks
Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.
Progress
40% Bias Score

Linoleic Acid Accelerates Triple-Negative Breast Cancer Growth
A study published in Science reveals that linoleic acid, an omega-6 fatty acid found in common foods, accelerates tumor growth in mice with triple-negative breast cancer (TNBC) by activating mTORC1 via the FABP5 protein, highlighting the need for personalized nutrition in cancer treatment.

Linoleic Acid Accelerates Triple-Negative Breast Cancer Growth
A study published in Science reveals that linoleic acid, an omega-6 fatty acid found in common foods, accelerates tumor growth in mice with triple-negative breast cancer (TNBC) by activating mTORC1 via the FABP5 protein, highlighting the need for personalized nutrition in cancer treatment.
Progress
64% Bias Score
Showing 1 to 3 of 3 results